Peptides in Wound Healing Research
Wound healing is one of the most actively studied applications for research peptides. Multiple peptides have demonstrated the ability to accelerate various phases of the healing process in research models.
Phases of Wound Healing
Wound healing involves four overlapping phases: Hemostasis (blood clotting), Inflammation (immune response), Proliferation (new tissue formation), and Remodeling (tissue maturation). Different peptides influence different phases.
Key Wound Healing Peptides
BPC-157 — Promotes angiogenesis, modulates growth factor expression (VEGF, FGF, EGF), and accelerates granulation tissue formation. One of the most extensively studied wound healing peptides. TB-500 — Promotes endothelial cell migration, angiogenesis, and anti-inflammatory effects. Upregulates actin polymerization essential for cell movement during wound repair. GHK-Cu — Stimulates collagen synthesis, glycosaminoglycan production, and attracts immune cells. The copper ion enhances antioxidant enzyme activity at the wound site. Wolverine Blend — Combines BPC-157 and TB-500 for synergistic healing through complementary mechanisms.
Research Models
Wound healing peptides are studied using: in vitro scratch assays, cell migration assays, animal wound models (incisional, excisional, burn), tendon and ligament injury models, and gastrointestinal damage models.
Mechanisms of Action
Research peptides promote healing through: increased angiogenesis (new blood vessel formation), enhanced collagen deposition, anti-inflammatory cytokine modulation, growth factor upregulation, and improved cell migration to wound sites.
Related Articles: BPC-157 Guide | TB-500 Benefits | Best Healing Peptides
For research use only. Shop wound healing peptides with third-party COAs at Proxiva Labs.